114 related articles for article (PubMed ID: 16082979)
1. Behavior of selected pharmaceuticals in subsurface flow constructed wetlands: a pilot-scale study.
Matamoros V; García J; Bayona JM
Environ Sci Technol; 2005 Jul; 39(14):5449-54. PubMed ID: 16082979
[TBL] [Abstract][Full Text] [Related]
2. Batch versus continuous feeding strategies for pharmaceutical removal by subsurface flow constructed wetland.
Zhang DQ; Gersberg RM; Zhu J; Hua T; Jinadasa KB; Tan SK
Environ Pollut; 2012 Aug; 167():124-31. PubMed ID: 22564400
[TBL] [Abstract][Full Text] [Related]
3. Removal of pharmaceuticals in microcosm constructed wetlands using Typha spp. and LECA.
Dordio A; Carvalho AJ; Teixeira DM; Dias CB; Pinto AP
Bioresour Technol; 2010 Feb; 101(3):886-92. PubMed ID: 19783427
[TBL] [Abstract][Full Text] [Related]
4. Behaviour of pharmaceutical products and biodegradation intermediates in horizontal subsurface flow constructed wetland. A microcosm experiment.
Matamoros V; Caselles-Osorio A; García J; Bayona JM
Sci Total Environ; 2008 May; 394(1):171-6. PubMed ID: 18280540
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical removal in tropical subsurface flow constructed wetlands at varying hydraulic loading rates.
Zhang DQ; Gersberg RM; Hua T; Zhu J; Tuan NA; Tan SK
Chemosphere; 2012 Apr; 87(3):273-7. PubMed ID: 22264861
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive assessment of the design configuration of constructed wetlands for the removal of pharmaceuticals and personal care products from urban wastewaters.
Hijosa-Valsero M; Matamoros V; Sidrach-Cardona R; Martín-Villacorta J; Bécares E; Bayona JM
Water Res; 2010 Jun; 44(12):3669-78. PubMed ID: 20494393
[TBL] [Abstract][Full Text] [Related]
7. Macrophytes may not contribute significantly to removal of nutrients, pharmaceuticals, and antibiotic resistance in model surface constructed wetlands.
Cardinal P; Anderson JC; Carlson JC; Low JE; Challis JK; Beattie SA; Bartel CN; Elliott AD; Montero OF; Lokesh S; Favreau A; Kozlova TA; Knapp CW; Hanson ML; Wong CS
Sci Total Environ; 2014 Jun; 482-483():294-304. PubMed ID: 24657374
[TBL] [Abstract][Full Text] [Related]
8. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac.
Zwiener C; Frimmel FH
Sci Total Environ; 2003 Jun; 309(1-3):201-11. PubMed ID: 12798104
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment.
Tauxe-Wuersch A; De Alencastro LF; Grandjean D; Tarradellas J
Water Res; 2005 May; 39(9):1761-72. PubMed ID: 15899274
[TBL] [Abstract][Full Text] [Related]
10. Capacity of a horizontal subsurface flow constructed wetland system for the removal of emerging pollutants: an injection experiment.
Avila C; Pedescoll A; Matamoros V; Bayona JM; García J
Chemosphere; 2010 Nov; 81(9):1137-42. PubMed ID: 20864142
[TBL] [Abstract][Full Text] [Related]
11. Elimination of pharmaceuticals and personal care products in subsurface flow constructed wetlands.
Matamoros V; Bayona JM
Environ Sci Technol; 2006 Sep; 40(18):5811-6. PubMed ID: 17007145
[TBL] [Abstract][Full Text] [Related]
12. Effects of constructed wetland design on ibuprofen removal - A mesocosm scale study.
Zhang L; Lv T; Zhang Y; Stein OR; Arias CA; Brix H; Carvalho PN
Sci Total Environ; 2017 Dec; 609():38-45. PubMed ID: 28734248
[TBL] [Abstract][Full Text] [Related]
13. Temporal evolution in PPCP removal from urban wastewater by constructed wetlands of different configuration: a medium-term study.
Reyes-Contreras C; Hijosa-Valsero M; Sidrach-Cardona R; Bayona JM; Bécares E
Chemosphere; 2012 Jun; 88(2):161-7. PubMed ID: 22436587
[TBL] [Abstract][Full Text] [Related]
14. Behavior of selected priority organic pollutants in horizontal subsurface flow constructed wetlands: a preliminary screening.
Matamoros V; Puigagut J; García J; Bayona JM
Chemosphere; 2007 Nov; 69(9):1374-80. PubMed ID: 17590410
[TBL] [Abstract][Full Text] [Related]
15. Selective determination of acidic pharmaceuticals in wastewater using molecularly imprinted solid-phase extraction.
Zorita S; Boyd B; Jönsson S; Yilmaz E; Svensson C; Mathiasson L; Bergström S
Anal Chim Acta; 2008 Sep; 626(2):147-54. PubMed ID: 18790115
[TBL] [Abstract][Full Text] [Related]
16. Effect of feeding strategies on pharmaceutical removal by subsurface flow constructed wetlands.
Zhang DQ; Gersberg RM; Hua T; Zhu J; Nguyen AT; Law WK; Ng WJ; Tan SK
J Environ Qual; 2012; 41(5):1674-80. PubMed ID: 23099959
[TBL] [Abstract][Full Text] [Related]
17. [Removal Behavior of Ibuprofen and Diclofenac in Different Constructed Wetlands].
Jing RY; Yang Y; Dai YN; Wan X; Tai YP; Fan JJ
Huan Jing Ke Xue; 2016 Jul; 37(7):2577-2585. PubMed ID: 29964465
[TBL] [Abstract][Full Text] [Related]
18. Removal of pharmaceuticals and personal care products (PPCPs) from urban wastewater in a pilot vertical flow constructed wetland and a sand filter.
Matamoros V; Arias C; Brix H; Bayona JM
Environ Sci Technol; 2007 Dec; 41(23):8171-7. PubMed ID: 18186355
[TBL] [Abstract][Full Text] [Related]
19. Emerging organic contaminants in vertical subsurface flow constructed wetlands: influence of media size, loading frequency and use of active aeration.
Avila C; Nivala J; Olsson L; Kassa K; Headley T; Mueller RA; Bayona JM; García J
Sci Total Environ; 2014 Oct; 494-495():211-7. PubMed ID: 25046612
[TBL] [Abstract][Full Text] [Related]
20. Removal of Pharmaceutical Products in a Constructed Wetland.
Özengin N; Elmaci A
Iran J Biotechnol; 2016 Dec; 14(4):221-229. PubMed ID: 28959339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
